Over the 90-day window ending February 19, 2026, Acrivon Therapeutics's three dominant insider ownership positions are held by Director Capital Management, L.P. Ra (7.91Mn shares), TenPercentOwner Ltd Chione (3.85Mn shares), TenPercentOwner Advisors Llc Perceptive (3.10Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Management, L.P. Ra | 7,914,206 | 15 Apr, 2024 | |
| Ltd Chione | 3,848,632 | 28 Jun, 2023 | |
| Advisors Llc Perceptive | 3,104,139 | 01 May, 2025 | |
| Kristina Masson | Evp Business Operations | 2,687,343 | 16 Aug, 2024 |
| Peter Blume-Jensen | President And Ceo | 2,410,477 | 16 Jan, 2026 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 888,130 | 21 Nov, 2022 | |
| Eric Devroe | Chief Operating Officer | 75,308 | 15 Jan, 2026 |
| Mary Miller | Chief Legal Officer | 33,896 | 21 Jan, 2026 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 26,088 | 19 Feb, 2025 |
| Adam D. Levy | Chief Financial Officer | 20,983 | 16 Jan, 2026 |
| Erick Gamelin | Chief Development Officer | 15,283 | 18 Nov, 2025 |
| Katharine Peterson | Chief Accounting Officer | 4,122 | 18 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Jan, 2026 | Mary Miller | Common Stock | D | 659 | $1.98 | 33,896 | D | F |
| 14 Jan, 2026 | Peter Blume-Jensen | Common Stock | A | 49,000 | $1.68 | 2,095,771 | D | P |
| 14 Jan, 2026 | Adam D. Levy | Common Stock | A | 8,832 | $1.70 | 20,983 | D | P |
| 13 Jan, 2026 | Eric Devroe | Common Stock | A | 10,000 | $1.72 | 75,308 | D | P |
| 21 Nov, 2025 | Peter Blume-Jensen | Common Stock | D | 19,904 | $2.30 | 2,046,771 | D | F |
| 14 Nov, 2025 | Mary Miller | Common Stock | D | 184 | $2.24 | 34,555 | D | F |
| 14 Nov, 2025 | Peter Blume-Jensen | - | - | 314,706 | I | |||
| 14 Nov, 2025 | Peter Blume-Jensen | Common Stock | D | 490 | $2.24 | 314,706 | I | F |
| 14 Nov, 2025 | Peter Blume-Jensen | Common Stock | D | 59,765 | $2.24 | 2,066,675 | D | F |
| 14 Nov, 2025 | Erick Gamelin | Common Stock | D | 403 | $2.24 | 15,283 | D | F |
| 14 Nov, 2025 | Eric Devroe | Common Stock | D | 613 | $2.24 | 65,308 | D | F |
| 14 Nov, 2025 | Katharine Peterson | - | - | 4,122 | D | |||
| 14 Nov, 2025 | Katharine Peterson | Common Stock | D | 99 | $2.24 | 4,122 | D | F |
| 17 Oct, 2025 | Mary Miller | Common Stock | D | 558 | $1.81 | 34,739 | D | F |
| 01 Oct, 2025 | Mary Miller | Common Stock | D | 284 | $1.81 | 35,297 | D | F |
| 21 Aug, 2025 | Peter Blume-Jensen | Common Stock | D | 19,905 | $1.32 | 2,126,440 | D | F |
| 14 Aug, 2025 | Mary Miller | Common Stock | D | 184 | $1.39 | 35,581 | D | F |
| 14 Aug, 2025 | Peter Blume-Jensen | Common Stock | D | 59,766 | $1.39 | 2,146,345 | D | F |
| 14 Aug, 2025 | Peter Blume-Jensen | Common Stock | D | 490 | $1.39 | 315,196 | I | F |
| 14 Aug, 2025 | Erick Gamelin | Common Stock | D | 403 | $1.39 | 15,686 | D | F |